Weighing in on the risks and benefits of probiotic use in HIV-infected and immunocompromised populations
- 27 February 2018
- journal article
- review article
- Published by Brill in Beneficial Microbes
- Vol. 9 (2) , 239-246
Abstract
Probiotics are used in the prophylaxis and treatment of several conditions, including irritable bowel syndrome, diarrhoea, necrotising enterocolitis (NEC) and colic in infants. Despite the long history of probiotic use in humans, there is still significant debate about their efficacy and safety, particularly in HIV-infected and immunocompromised individuals. Here, we reviewed the safety and adverse event (AE) reporting from clinical trials that have tested probiotics in at risk populations, including HIV-infected individuals, the terminally ill and elderly, and neonates. Our analysis suggests that the benefits of probiotic therapy outweigh their potential risks in HIV-infected populations, and in the treatment of colic and NEC in low birth weight or premature neonates. Most case reports of severe AEs were in the elderly and terminally ill, or in those with additional severe medical conditions. We conclude that probiotic use, as adjunctive treatment, is effective and safe in the majority of patients including HIV-infected individuals, although special care should be taken in individuals with extreme immunosuppression and severe medical conditions in all ages.Keywords
This publication has 49 references indexed in Scilit:
- Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic diseaseBMC Microbiology, 2013
- Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trialNutrition Journal, 2012
- Effect of Micronutrient and Probiotic Fortified Yogurt on Immune-Function of Anti-Retroviral Therapy Naive HIV Patients
Nutrients, 2011
- Fecal Microbiota in Premature Infants Prior to Necrotizing EnterocolitisPLOS ONE, 2011
- Folate Production by Probiotic BacteriaNutrients, 2011
- Lactobacillus rhamnosus GR‐1 and L. reuteri RC‐14 to prevent or cure bacterial vaginosis among women with HIVInternational Journal of Gynecology & Obstetrics, 2010
- 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitisThe ISME Journal, 2009
- Intestinal Permeability in Preterm Infants by Feeding Type: Mother's Milk Versus FormulaBreastfeeding Medicine, 2009
- Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L . reuteri DSM 17938Applied and Environmental Microbiology, 2008
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006